INNA-051
Prophylaxis against viral respiratory infections (e.g., SARS‑CoV‑2, influenza, rhinovirus)
Phase 2Active
Key Facts
Indication
Prophylaxis against viral respiratory infections (e.g., SARS‑CoV‑2, influenza, rhinovirus)
Phase
Phase 2
Status
Active
Company
About ENA Respiratory
Pan‑viral nasal spray prophylaxis using a TLR2/6 agonist to protect vulnerable patients from respiratory infections.
View full company profile